Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Cladribine [USAN:USP:INN:BAN]
RN: 4291-63-8
UNII: 47M74X9YT5
InChIKey: PTOAARAWEBMLNO-KVQBGUIXSA-N

Note

  • An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.

Molecular Formula

  • C10-H12-Cl-N5-O3

Molecular Weight

  • 285.69
 

Classification Codes

  • Antineoplastic
  • Antineoplastic Agents
  • Drug / Therapeutic Agent
  • Human Data
  • Immunologic Factors
  • Immunosuppressive Agents
  • Mutation Data
  • Reproductive Effect
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Cladribine
  • Cladribine [USAN:USP:INN:BAN]

MeSH Heading

  • Cladribine

Synonyms

  • 2-CDA
  • 2-Chloro-2'-deoxy-beta-adenosine
  • 2-Chloro-2'-deoxyadenosine
  • 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine
  • 2-Chlorodeoxyadenosine
  • Adenosine, 2-chloro-2'-deoxy-
  • BRN 0624220
  • CCRIS 9374
  • Chlorodeoxyadenosine
  • Cladarabine
  • Cladribine
  • HSDB 7564
  • Leustatin
  • NSC 105014
  • NSC 105014-F
  • RWJ 26251
  • UNII-47M74X9YT5

Systematic Name

  • Adenosine, 2-chloro-2'-deoxy-

Superlist Name

  • Cladribine

Registry Numbers

CAS Registry Number

  • 4291-63-8

FDA UNII

  • 47M74X9YT5

Other Registry Number

  • 24757-90-2

System Generated Number

  • 0004291638

Structure Descriptors

InChI

InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1

InChIKey

PTOAARAWEBMLNO-KVQBGUIXSA-N

Smiles

Nc1nc(Cl)nc2c1ncn2[C@H]3C[C@H](O)[C@@H](CO)O3

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo intravenous 700ug/kg/7D-C (0.7mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" American Journal of Hematology. Vol. 53, Pg. 209, 1996.
mouse LD50 intraperitoneal 150mg/kg (150mg/kg)   Leukemia and Lymphoma. Vol. 5, Pg. 1, 1991.